Scientific Sessions

Recent updates in pediatric endocrine disorders highlight advancements in diagnosis and treatment, improving outcomes for children with hormonal imbalances. Conditions such as diabetes, thyroid disorders, and growth hormone deficiencies require precise management strategies tailored to pediatric needs. Advances in continuous glucose monitoring (CGM) and insulin pump technology have revolutionized diabetes care, offering real-time data and more stable blood sugar control for children with type 1 diabetes. For thyroid disorders, refined diagnostic criteria and new treatment protocols ensure earlier detection and more effective management of hypothyroidism and hyperthyroidism. Growth hormone therapy for growth hormone deficiencies and other growth disorders has seen improvements in formulation and delivery methods, enhancing efficacy and patient adherence. Additionally, novel therapies targeting specific genetic mutations in conditions like congenital adrenal hyperplasia (CAH) show promise in personalized medicine approaches. Ongoing research and clinical trials continue to expand our understanding, leading to innovative treatments and better quality of life for children affected by endocrine disorders.